Article Details

Cytokinetics heart drug succeeds in mid-stage study, boosting shares

Retrieved on: 2021-07-19 16:18:45

Tags for this article:

Click the tags to see associated articles and topics

Cytokinetics heart drug succeeds in mid-stage study, boosting shares. View article details on hiswai:

Excerpt

An FDA decision on Myokardia's drug, called mavacamten, is expected by late January. Recommended Reading: BioPharma Dive Amgen cuts ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up